Meclofenamic acid has been proven to be a specific inhibitor of FTO compared to ALKBH5, showing increased m6A levels and reduced proliferation in acute myeloid leukemia and GSCs [116,117]. The gene discussed is FTO; the disease is acute myeloid leukemia.